Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Corey

Showing results (61-70 of 551) with videos related to

Pageof 56
Sort By:
Frontiers in Microbiology|May 6, 2014
Nuclear factor kappa B is required for the production of infectious human herpesvirus 8 virionsNegin N Blattman, Michael Lagunoff, Joseph N Blattman, et al.
Lancet (London, England)|October 22, 2020
Use of adenovirus type-5 vectored vaccines: a cautionary taleSusan P Buchbinder, M Juliana McElrath, Carl Dieffenbach, et al.
American Journal of Infection Control|November 6, 2007
Antimicrobial resistance prevention initiative--an update: proceedings of an expert panel on resistanceRobert C Moellering, John R Graybill, John E McGowan, et al.
The Journal of Infectious Diseases|July 28, 2011
The kinetics of mucosal herpes simplex virus-2 infection in humans: evidence for rapid viral-host interactionsJoshua T Schiffer, Anna Wald, Stacy Selke, et al.
Vaccine|October 26, 2005
Antiretroviral therapy for HIV-1 vaccine efficacy trial participants who seroconvertH Nina Kim, Stephen R Tabet, Lawrence Corey, et al.
The Journal of Infectious Diseases|January 25, 2002
High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infectionW Garrett Nichols, Lawrence Corey, Ted Gooley, et al.
The Journal of Infectious Diseases|June 16, 2007
Use of long-term suppressive acyclovir after hematopoietic stem-cell transplantation: impact on herpes simplex virus (HSV) disease and drug-resistant HSV diseaseVeronique Erard, Anna Wald, Lawrence Corey, et al.
Journal of Virology|December 7, 2007
Independent and cooperative antiviral actions of beta interferon and gamma interferon against herpes simplex virus replication in primary human fibroblastsTao Peng, Jia Zhu, Yon Hwangbo, et al.
Journal of Virology|October 18, 2005
How many human immunodeficiency virus type 1-infected target cells can a cytotoxic T-lymphocyte kill?W David Wick, Otto O Yang, Lawrence Corey, et al.
Cold Spring Harbor Perspectives in Medicine|December 5, 2012
Human immunodeficiency virus vaccine trialsRobert J O'Connell, Jerome H Kim, Lawrence Corey, et al.
Pageof 56

Showing results (61-70 of 551) with videos related to

Sort By:
Pageof 56
Frontiers in Microbiology|May 6, 2014
Nuclear factor kappa B is required for the production of infectious human herpesvirus 8 virionsNegin N Blattman, Michael Lagunoff, Joseph N Blattman, et al.
Lancet (London, England)|October 22, 2020
Use of adenovirus type-5 vectored vaccines: a cautionary taleSusan P Buchbinder, M Juliana McElrath, Carl Dieffenbach, et al.
American Journal of Infection Control|November 6, 2007
Antimicrobial resistance prevention initiative--an update: proceedings of an expert panel on resistanceRobert C Moellering, John R Graybill, John E McGowan, et al.
The Journal of Infectious Diseases|July 28, 2011
The kinetics of mucosal herpes simplex virus-2 infection in humans: evidence for rapid viral-host interactionsJoshua T Schiffer, Anna Wald, Stacy Selke, et al.
Vaccine|October 26, 2005
Antiretroviral therapy for HIV-1 vaccine efficacy trial participants who seroconvertH Nina Kim, Stephen R Tabet, Lawrence Corey, et al.
The Journal of Infectious Diseases|January 25, 2002
High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infectionW Garrett Nichols, Lawrence Corey, Ted Gooley, et al.
The Journal of Infectious Diseases|June 16, 2007
Use of long-term suppressive acyclovir after hematopoietic stem-cell transplantation: impact on herpes simplex virus (HSV) disease and drug-resistant HSV diseaseVeronique Erard, Anna Wald, Lawrence Corey, et al.
Journal of Virology|December 7, 2007
Independent and cooperative antiviral actions of beta interferon and gamma interferon against herpes simplex virus replication in primary human fibroblastsTao Peng, Jia Zhu, Yon Hwangbo, et al.
Journal of Virology|October 18, 2005
How many human immunodeficiency virus type 1-infected target cells can a cytotoxic T-lymphocyte kill?W David Wick, Otto O Yang, Lawrence Corey, et al.
Cold Spring Harbor Perspectives in Medicine|December 5, 2012
Human immunodeficiency virus vaccine trialsRobert J O'Connell, Jerome H Kim, Lawrence Corey, et al.
Pageof 56